• MJHLS Brand Logo

© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.

Management of Progressive Multiple Sclerosis

Experts discuss the diagnosis and treatment of progressive multiple sclerosis.

EP. 1: Clinical Subtypes of MS

March 18th 2021

A panel of experts led by Bruce Cree, MD, highlight the clinical subtypes of multiple sclerosis including presentation and prevalence.

EP. 2: Diagnosing SPMS

March 18th 2021

An overview of the criteria used to diagnose relapsing-remitting multiple sclerosis when it converts to secondary progressive multiple sclerosis.

EP. 3: Classification and Diagnosis of SPMS

March 24th 2021

Fred D. Lublin, MD, leads a discussion about the different classifications of secondary progressive multiple sclerosis, including the relationship between disease activity and progression of disease.

EP. 4: Treating PPMS Versus SPMS

March 25th 2021

A comparison of various factors considered when treating primary progressive multiple sclerosis versus secondary progressive multiple sclerosis.

EP. 5: Siponimod for SPMS Treatment

April 1st 2021

Robert Fox, MD, discusses the rationale for using siponimod for the treatment of progressive multiple sclerosis as well as the practical implications of the phase 3 EXPAND trial.

EP. 6: MS Treatment: EXPAND Study Versus ASCEND Study

April 1st 2021

Experts in the field of multiple sclerosis compare the results of the EXPAND study to the results of the ASCEND study.

EP. 7: Progressive MS Treatment: Ocrelizumab

April 8th 2021

Kristen Krysko, MD, summarizes the results of the phase III ORATORIO trial and discusses the rationale for using ocrelizumab for the treatment of progressive multiple sclerosis.  

EP. 8: Patient Selection in MS Treatment

April 8th 2021

Experts in the field of multiple sclerosis discuss patient selection for drugs based on disease activity.

EP. 9: Nonactive MS: Treatment Therapies

April 15th 2021

A discussion of how experts treat nonactive multiple sclerosis in terms of trial results or symptom management and how decisions are based on patient age.

EP. 10: Ibudilast for Progressive Treatment

April 15th 2021

Experts in progressive multiple sclerosis summarize the phase 2 SPRINT-MS trial and the rationale for treating patients with ibudilast.